Literature DB >> 12003429

The insensitivity of endoscopic markers in celiac disease.

Amy S Oxentenko1, Scott W Grisolano, Joseph A Murray, Lawrence J Burgart, Ross A Dierkhising, Jeffrey A Alexander.   

Abstract

OBJECTIVES: Celiac disease (CD) is characterized by small intestinal inflammation and mucosal atrophy. Endoscopic markers of villous atrophy are reported to be present in 88-100% of untreated celiac patients. In patients being evaluated for iron deficiency anemia (IDA), we examined whether endoscopic markers could predict histological results consistent with CD.
METHODS: One hundred thirteen patients without histories of CD had small bowel biopsies to evaluate IDA using videoendoscopy. Markers suggesting villous atrophy were noted at endoscopy. Biopsy specimens were reviewed for consistency with CD. Endoscopic and histological findings were compared.
RESULTS: Seventeen patients were diagnosed with CD, both clinically and histologically. Loss of folds was the most sensitive marker of villous atrophy, present in 47% with CD, with 97% specificity. The mosaic pattern was much less sensitive (12%), with 100% specificity. Nodularity and scalloping had low sensitivities (6%), but specificities of 95% and 100%, respectively. A finding of any endoscopic marker yielded a sensitivity of 59% and specificity of 92% for CD.
CONCLUSIONS: Although endoscopic markers have been guides for directing small bowel biopsies in patients suspected of having CD, we found sensitivities of these markers to be low and conclude that they should not be relied upon for detecting CD in patients presenting with IDA.

Entities:  

Mesh:

Year:  2002        PMID: 12003429     DOI: 10.1111/j.1572-0241.2002.05612.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  28 in total

1.  Changing presentation of adult celiac disease.

Authors:  Winson Lo; Kevin Sano; Ben Lebwohl; Beverly Diamond; Peter H R Green
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

2.  Quantitative assessment of endoscopic images for degree of villous atrophy in celiac disease.

Authors:  Edward J Ciaccio; Govind Bhagat; Christina A Tennyson; Suzanne K Lewis; Lincoln Hernandez; Peter H R Green
Journal:  Dig Dis Sci       Date:  2010-09-16       Impact factor: 3.199

3.  Capsule endoscopy in nonresponsive celiac disease.

Authors:  David S Atlas; Alberto Rubio-Tapia; Carol T Van Dyke; Brian D Lahr; Joseph A Murray
Journal:  Gastrointest Endosc       Date:  2011-08-11       Impact factor: 9.427

Review 4.  Hematologic manifestations of celiac disease.

Authors:  Thorvardur R Halfdanarson; Mark R Litzow; Joseph A Murray
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

5.  High-resolution magnifying upper endoscopy in a patient with patchy celiac disease.

Authors:  Giovanni Cammarota; Antonio Martino; Simona Di Caro; Rossella Cianci; Piera G Lecca; Fabio M Vecchio; Giovanni Gasbarrini
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

Review 6.  Advances in diagnosis and management of celiac disease.

Authors:  Ciarán P Kelly; Julio C Bai; Edwin Liu; Daniel A Leffler
Journal:  Gastroenterology       Date:  2015-02-03       Impact factor: 22.682

7.  Optical coherence tomography in the diagnosis of coeliac disease: a preliminary report.

Authors:  E Masci; B Mangiavillano; L Albarello; A Mariani; C Doglioni; P A Testoni
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

Review 8.  Pearls and pitfalls in the diagnosis of adult celiac disease.

Authors:  H J Freeman
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

Review 9.  Emerging technologies in upper gastrointestinal endoscopy and celiac disease.

Authors:  Giovanni Cammarota; Paolo Fedeli; Antonio Gasbarrini
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-11-11

Review 10.  Endoscopic tools for the diagnosis and evaluation of celiac disease.

Authors:  Gianluca Ianiro; Antonio Gasbarrini; Giovanni Cammarota
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.